Oxidative Stress Management in Cardiorenal Diseases: Focus on Novel Antidiabetic Agents, Finerenone, and Melatonin
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oxidative Stress Management in Cardiorenal Diseases: Focus on Novel Antidiabetic Agents, Finerenone, and Melatonin
Authors
Keywords
-
Journal
Life-Basel
Volume 12, Issue 10, Pages 1663
Publisher
MDPI AG
Online
2022-10-21
DOI
10.3390/life12101663
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Temporal effect of melatonin posttreatment on anoxia/reoxygenation injury in H9c2 cells
- (2022) Yang Bai et al. CELL BIOLOGY INTERNATIONAL
- Melatonin supplementation improves N‐terminal pro‐B‐type natriuretic peptide levels and quality of life in patients with heart failure with reduced ejection fraction: Results from MeHR trial, a randomized clinical trial
- (2022) Shervin G. Hoseini et al. CLINICAL CARDIOLOGY
- Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice
- (2022) Edouard L. Fu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Melatonin Attenuates Ischemia/Reperfusion-Induced Oxidative Stress by Activating Mitochondrial Fusion in Cardiomyocytes
- (2022) Xiaoling Ma et al. Oxidative Medicine and Cellular Longevity
- Empagliflozin Enhances Autophagy, Mitochondrial Biogenesis, and Antioxidant Defense and Ameliorates Renal Ischemia/Reperfusion in Nondiabetic Rats
- (2022) Moein Ala et al. Oxidative Medicine and Cellular Longevity
- Melatonin protected against myocardial infarction injury in rats through a Sirt6-dependent antioxidant pathway
- (2022) Yingcui Wang et al. Advances in Clinical and Experimental Medicine
- The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs
- (2022) Dario Giugliano et al. Cardiovascular Diabetology
- Therapeutic potential of a single-dose melatonin in the attenuation of cardiac ischemia/reperfusion injury in prediabetic obese rats
- (2022) Kodchanan Singhanat et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Pleiotropic effects of SGLT2 inhibitors and heart failure outcomes
- (2022) Panagiotis Theofilis et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
- (2022) Thomas Karagiannis et al. DIABETOLOGIA
- Liraglutide treatment attenuates inflammation markers in the cardiac, cerebral and renal microvasculature in streptozotocin‐induced diabetic rats
- (2022) Umit Baylan et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Evaluation of Melatonin Therapy in Patients with Myocardial Ischemia-Reperfusion Injury: A Systematic Review and Meta-Analysis
- (2022) Tingting Lv et al. Oxidative Medicine and Cellular Longevity
- Empagliflozin Ameliorates Diabetic Cardiomyopathy via Attenuating Oxidative Stress and Improving Mitochondrial Function
- (2022) Jinwu Wang et al. Oxidative Medicine and Cellular Longevity
- Effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on podocytes, inflammation, and oxidative stress in patients with diabetic nephropathy (DN)
- (2022) Jie Liu et al. Pakistan Journal of Medical Sciences
- The impact of SGLT2 inhibition on imaging markers of cardiac function: A systematic review and meta-analysis
- (2022) Panagiotis Theofilis et al. PHARMACOLOGICAL RESEARCH
- Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of double-blind, randomized, placebo-controlled clinical trials
- (2022) Jing Qin et al. BMC Endocrine Disorders
- Inflammation-sensing catalase-mimicking nanozymes alleviate acute kidney injury via reversing local oxidative stress
- (2022) Hong Sang Choi et al. JOURNAL OF NANOBIOTECHNOLOGY
- Setanaxib (GKT137831) Ameliorates Doxorubicin-Induced Cardiotoxicity by Inhibiting the NOX1/NOX4/Reactive Oxygen Species/MAPK Pathway
- (2022) Hui Zheng et al. Frontiers in Pharmacology
- Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial
- (2022) Tim Heise et al. Lancet Diabetes & Endocrinology
- Novel dual glucagon-like peptide-1/ glucose-dependent insulinotropic polypeptide receptor agonist attenuates diabetes and myocardial injury through inhibiting hyperglycemia, inflammation and oxidative stress in rodent animals
- (2022) Ying Wang et al. Bioengineered
- Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis
- (2022) Mohamed El-Shafey et al. Frontiers in Endocrinology
- Epidemiology of chronic kidney disease: an update 2022
- (2022) Csaba P. Kovesdy Kidney International Supplements
- Effects of the SGLT2 Inhibition on Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats, a Model of Type 1 Diabetes Mellitus
- (2022) Camila Moreno Rosa et al. Antioxidants
- Direct Cardiac Actions of Sodium-Glucose Cotransporter 2 Inhibition Improve Mitochondrial Function and Attenuate Oxidative Stress in Pressure Overload-Induced Heart Failure
- (2022) Xuan Li et al. Frontiers in Cardiovascular Medicine
- The Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal?
- (2022) Panagiotis Theofilis et al. AMERICAN JOURNAL OF NEPHROLOGY
- H2O2-Activatable Antioxidant Polymeric Prodrug Nanoparticles for the Prevention of Renal Ischemia/Reperfusion Injury
- (2022) Hyeonbin Shin et al. BIOMACROMOLECULES
- Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme Inhibition
- (2022) Yuliya Lytvyn et al. CIRCULATION
- Major adverse cardiovascular and limb events in people with diabetes treated with GLP-1 receptor agonists vs SGLT2 inhibitors
- (2022) Donna Shu-Han Lin et al. DIABETOLOGIA
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial
- (2022) Nobuya Inagaki et al. Lancet Diabetes & Endocrinology
- Empagliflozin Attenuates Obesity-Related Kidney Dysfunction and NLRP3 Inflammasome Activity Through the HO-1–Adiponectin Axis
- (2022) Tongtong Ye et al. Frontiers in Endocrinology
- Effect of glucagon-like peptide 1 receptor agonists on the renal protection in patients with type 2 diabetes: A systematic review and meta-analysis
- (2022) Xiang Li et al. DIABETES & METABOLISM
- Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme
- (2022) Faiez Zannad et al. EUROPEAN HEART JOURNAL
- Dimethyl Fumarate Attenuates Di-(2-Ethylhexyl) Phthalate-Induced Nephrotoxicity Through the Nrf2/HO-1 and NF-κB Signaling Pathways
- (2022) Sorour Ashari et al. INFLAMMATION
- The impact of SGLT2 inhibitors on inflammation: A systematic review and meta-analysis of studies in rodents
- (2022) Panagiotis Theofilis et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Dapagliflozin Mitigates Doxorubicin-Caused Myocardium Damage by Regulating AKT-Mediated Oxidative Stress, Cardiac Remodeling, and Inflammation
- (2022) Pei-Ling Hsieh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Empagliflozin prohibits high-fructose diet-induced cardiac dysfunction in rats via attenuation of mitochondria-driven oxidative stress
- (2022) Paramesha Bugga et al. LIFE SCIENCES
- Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
- (2022) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Beneficial Effects of Empagliflozin Are Mediated by Reduced Renal Inflammation and Oxidative Stress in Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein
- (2022) Hana Malínská et al. Biomedicines
- Effects of Melatonin and Adrenomedullin in Reducing the Cardiotoxic Effects of Doxorubicin in Rats
- (2021) Gulcin Durdagi et al. Cardiovascular Toxicology
- Protective effects of dapagliflozin against oxidative stress-induced cell injury in human proximal tubular cells
- (2021) Nawel Zaibi et al. PLoS One
- Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK
- (2021) Kun-Ling Tsai et al. Cell and Bioscience
- Glucagon‐like peptide‐1 receptor agonists improve biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomised controlled trials
- (2021) Jonathan J. H. Bray et al. DIABETES OBESITY & METABOLISM
- Melatonin and Cardioprotection in Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2021) Alberto Domínguez-Rodríguez et al. Frontiers in Cardiovascular Medicine
- SGLT2 inhibitor empagliflozin monotherapy alleviates renal oxidative stress in albino Wistar diabetic rats after myocardial infarction induction
- (2021) Ahmed S. Ahmed et al. BIOMEDICINE & PHARMACOTHERAPY
- SGLT2 inhibition for cardiovascular diseases, chronic kidney disease and NAFLD
- (2021) Moein Ala ENDOCRINOLOGY
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2021) Theresa A McDonagh et al. EUROPEAN HEART JOURNAL
- Melatonin improves the antioxidant capacity in cardiac tissue of Wistar rats after exhaustive exercise
- (2021) Rafael Ishihara et al. FREE RADICAL RESEARCH
- Cardioprotective effects of melatonin against myocardial ischaemia/reperfusion injury: Activation of AMPK/Nrf2 pathway
- (2021) Chennian Xu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Epidemiology of cardiovascular disease in Europe
- (2021) Nick Townsend et al. Nature Reviews Cardiology
- Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
- (2021) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence of SGLT2 Inhibitor Treatment on Urine Antioxidant Status in Type 2 Diabetic Patients: A Pilot Study
- (2021) Diana Nabrdalik-Leśniak et al. Oxidative Medicine and Cellular Longevity
- Activation of Nrf2 Pathway by Dimethyl Fumarate Attenuates Renal Ischemia-Reperfusion Injury
- (2021) Xu Zhen et al. TRANSPLANTATION PROCEEDINGS
- A SGLT2 Inhibitor Dapagliflozin Alleviates Diabetic Cardiomyopathy by Suppressing High Glucose-Induced Oxidative Stress in vivo and in vitro
- (2021) Yu-jie Xing et al. Frontiers in Pharmacology
- Effects of a 12-Month Treatment with Glucagon-like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Oxidant and Antioxidant Biomarkers in Patients with Type 2 Diabetes
- (2021) Vaia Lambadiari et al. Antioxidants
- Inflammatory Mechanisms Contributing to Endothelial Dysfunction
- (2021) Panagiotis Theofilis et al. Biomedicines
- Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics
- (2021) Apiwan Arinno et al. BIOCHEMICAL PHARMACOLOGY
- Empagliflozin reduces oxidative stress through inhibition of the novel inflammation/NHE/[Na+]c/ROS-pathway in human endothelial cells
- (2021) Laween Uthman et al. BIOMEDICINE & PHARMACOTHERAPY
- The effect of sodium-glucose cotransporter 2 inhibitor (tofogliflozin) on renal tubular damage in diabetic patients without albuminuria
- (2021) Homare Shimohata et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Cardioprotective Effects of Glucagon-like Peptide-1 (9-36) Against Oxidative Injury in H9c2 Cardiomyoblasts: Potential Role of the PI3K/Akt/NOS Pathway
- (2021) Narawat Nuamnaichati et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Regression of diabetic nephropathy by treatment with empagliflozin in BTBR ob/ob mice
- (2021) Kelly L Hudkins et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Co-administration of melatonin and insulin improves diabetic-induced impairment of rat kidney function
- (2021) Younis Ahmad Hajam et al. NEUROENDOCRINOLOGY
- Corrigendum to “Melatonin Attenuates Diabetic Myocardial Microvascular Injury through Activating the AMPK/SIRT1 Signaling Pathway”
- (2021) Bin Wang et al. Oxidative Medicine and Cellular Longevity
- Melatonin receptor protects cardiomyocyte against oxidative stress-induced apoptosis through the MAPK-ERK signaling pathway
- (2020) Peng Li et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Folic acid and melatonin mitigate diabetic nephropathy in rats via inhibition of oxidative stress
- (2020) Hossam Ebaid et al. Nutrition & Metabolism
- Melatonin Prevents Transforming Growth Factor-β1-Stimulated Transdifferentiation of Renal Interstitial Fibroblasts to Myofibroblasts by Suppressing Reactive Oxygen Species-Dependent Mechanisms
- (2020) Jung-Yeon Kim et al. Antioxidants
- Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation
- (2020) Detmar Kolijn et al. CARDIOVASCULAR RESEARCH
- Melatonin modulates acute cardiac muscle damage induced by carbon tetrachloride – involvement of oxidative damage, glutathione, and arginine/NO metabolism
- (2020) Snezana Ćirić Zdravković et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Discontinuation rate and reason for discontinuation after sodium‐glucose cotransporter 2 inhibitor prescription in real clinical practice
- (2020) Hyunah Kim et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Melatonin ameliorates PM 2.5 ‐induced cardiac perivascular fibrosis through regulating mitochondrial redox homeostasis
- (2020) Jinjin Jiang et al. JOURNAL OF PINEAL RESEARCH
- Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Results of DAPA-HF
- (2020) Pardeep S. Jhund et al. CIRCULATION
- Low-dose lixisenatide protects against early-onset nephropathy induced in diabetic rats
- (2020) Rania G. Abdel-latif et al. LIFE SCIENCES
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
- (2020) George L. Bakris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Melatonin alleviates angiotensin-II-induced cardiac hypertrophy via activating MICU1 pathway
- (2020) Yi Yang et al. Aging-US
- Salvianolate ameliorates oxidative stress and podocyte injury through modulation of NOX4 activity in db/db mice
- (2020) Yiran Liang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin, an SGLT2 inhibitor, normalizes renal susceptibility to type 1 cardiorenal syndrome through reduction of renal oxidative stress in diabetic rats
- (2019) Yukishige Kimura et al. Journal of Diabetes Investigation
- Melatonin protects against streptozotocin-induced diabetic cardiomyopathy through themammalian target of rapamycin (mTOR) signaling pathway
- (2019) yasemin kandemir et al. Advances in Clinical and Experimental Medicine
- Liraglutide, a glucagon‑like peptide‑1 analog, inhibits high glucose‑induced oxidative stress and apoptosis in neonatal rat cardiomyocytes
- (2019) Lihui Zhang et al. Experimental and Therapeutic Medicine
- Activation of Melatonin Receptor 2 But Not Melatonin Receptor 1 Mediates Melatonin‐conferred Cardio‐protection Against Myocardial Ischemia/Reperfusion Injury
- (2019) Dong Han et al. JOURNAL OF PINEAL RESEARCH
- SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
- (2019) Chenguang Li et al. Cardiovascular Diabetology
- Sodium–glucose co‐transporter 2 inhibition with empagliflozin improves cardiac function in non‐diabetic rats with left ventricular dysfunction after myocardial infarction
- (2019) Salva R. Yurista et al. EUROPEAN JOURNAL OF HEART FAILURE
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Melatonin protects circulatory death heart from ischemia/reperfusion injury via the JAK2/STAT3 signalling pathway
- (2019) Hongwen Lan et al. LIFE SCIENCES
- Association of Nrf2, SOD2 and GPX1 Polymorphisms with Biomarkers of Oxidative Distress and Survival in End-Stage Renal Disease Patients
- (2019) Djurdja Jerotic et al. Toxins
- The effect of oral melatonin on renal ischemia–reperfusion injury in transplant patients: A double-blind, randomized controlled trial
- (2019) Fatemeh Panah et al. TRANSPLANT IMMUNOLOGY
- The Effects of Melatonin Supplementation on Parameters of Mental Health, Glycemic Control, Markers of Cardiometabolic Risk, and Oxidative Stress in Diabetic Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2019) Vahidreza Ostadmohammadi et al. JOURNAL OF RENAL NUTRITION
- Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis
- (2019) Lian-Jiu Su et al. Oxidative Medicine and Cellular Longevity
- The Effects of Dimethyl Fumarate on Atherosclerosis in the Apolipoprotein E-Deficient Mouse Model with Streptozotocin-Induced Hyperglycemia Mediated By the Nuclear Factor Erythroid 2-Related Factor 2/Antioxidant Response Element (Nrf2/ARE) Signaling Pathway
- (2019) Man Luo et al. MEDICAL SCIENCE MONITOR
- Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition
- (2019) Nitin A. Das et al. CELLULAR SIGNALLING
- Short- and long-term administration of the non-steroidal mineralocorticoid receptor antagonist finerenone opposes metabolic syndrome-related cardio-renal dysfunction
- (2018) Marianne Lachaux et al. DIABETES OBESITY & METABOLISM
- Glucagon‑like peptide‑1 protects mouse podocytes against high glucose‑induced apoptosis, and suppresses reactive oxygen species production and proinflammatory cytokine secretion, through sirtuin 1 activation in�vitro
- (2018) Jian‑Xia Shi et al. Molecular Medicine Reports
- Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end-stage renal disease patients of Han Chinese origin
- (2018) Chia-Ter Chao et al. NEPHROLOGY
- Nox1/4 dual inhibitor GKT137831 attenuates hypertensive cardiac remodelling associating with the inhibition of ADAM17-dependent proinflammatory cytokines-induced signalling pathways in the rats with abdominal artery constriction
- (2018) Si-yu Zeng et al. BIOMEDICINE & PHARMACOTHERAPY
- The Role of Vitamin D and Oxidative Stress in Chronic Kidney Disease
- (2018) Keith Norris et al. International Journal of Environmental Research and Public Health
- Finerenone Attenuates Endothelial Dysfunction and Albuminuria in a Chronic Kidney Disease Model by a Reduction in Oxidative Stress
- (2018) Raquel González-Blázquez et al. Frontiers in Pharmacology
- Benefit of Mineralocorticoid Receptor Antagonism in AKI: Role of Vascular Smooth Muscle Rac1
- (2017) Jonatan Barrera-Chimal et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Diabetes and Kidney Disease: Role of Oxidative Stress
- (2016) Jay C. Jha et al. ANTIOXIDANTS & REDOX SIGNALING
- NADPH Oxidase-2 and AtherothrombosisHighlights
- (2016) Francesco Violi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Vascular Smooth Muscle Mineralocorticoid Receptor Contributes to Coronary and Left Ventricular Dysfunction After Myocardial InfarctionNovelty and Significance
- (2016) Alexandre Gueret et al. HYPERTENSION
- Hydrogen Peroxide‐Responsive Nanoparticle Reduces Myocardial Ischemia/Reperfusion Injury
- (2016) Soochan Bae et al. Journal of the American Heart Association
- Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular RemodelingSignificance
- (2015) Stephen P. Gray et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- NADPH Oxidase 4 Induces Cardiac Fibrosis and Hypertrophy Through Activating Akt/mTOR and NF B Signaling Pathways
- (2015) Q. D. Zhao et al. CIRCULATION
- NADPH oxidase 4 protects against development of endothelial dysfunction and atherosclerosis in LDL receptor deficient mice
- (2015) Heike Langbein et al. EUROPEAN HEART JOURNAL
- The NADPH oxidase Nox4 has anti-atherosclerotic functions
- (2015) Christoph Schürmann et al. EUROPEAN HEART JOURNAL
- Effect of Glucagon-like Peptide-1 on High-Glucose-induced Oxidative Stress and Cell Apoptosis in Human Endothelial Cells and Its Underlying Mechanism
- (2015) Rehua Wang et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Protective Role of Glucagon-Like Peptide-1 Against High-Glucose-Induced Endothelial Oxidative Damage
- (2015) Lixin Guo et al. MEDICINE
- Treatment With Dimethyl Fumarate Attenuates Calcineurin Inhibitor-induced Nephrotoxicity
- (2015) Chie Takasu et al. TRANSPLANTATION
- Xanthine oxidoreductase in atherosclerosis pathogenesis: Not only oxidative stress
- (2014) Maria Giulia Battelli et al. ATHEROSCLEROSIS
- NOX1 deficiency in apolipoprotein E-knockout mice is associated with elevated plasma lipids and enhanced atherosclerosis
- (2014) C. G. Sobey et al. FREE RADICAL RESEARCH
- Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy
- (2014) J. C. Jha et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of Redox Modulating NRF2 Activators on Chronic Kidney Disease
- (2014) Bo-hyun Choi et al. MOLECULES
- Manganese Superoxide Dismutase (SOD2) Polymorphisms, Plasma Advanced Oxidation Protein Products (AOPP) Concentration and Risk of Kidney Complications in Subjects with Type 1 Diabetes
- (2014) Kamel Mohammedi et al. PLoS One
- Glucagon-Like Peptide 1 Reduces Endothelial Dysfunction, Inflammation, and Oxidative Stress Induced by Both Hyperglycemia and Hypoglycemia in Type 1 Diabetes
- (2013) A. Ceriello et al. DIABETES CARE
- Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune–inflammatory responses in diabetic Apoe −/− mice
- (2013) E. Di Marco et al. DIABETOLOGIA
- Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
- (2013) Bertram Pitt et al. EUROPEAN HEART JOURNAL
- Combined Polymorphisms in Oxidative Stress Genes Predict Coronary Artery Disease and Oxidative Stress in Coronary Angiography Patients
- (2012) Claire L. Heslop et al. ANNALS OF HUMAN GENETICS
- The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells
- (2012) Aya Shiraki et al. ATHEROSCLEROSIS
- Endothelial-specific Nox2 overexpression increases vascular superoxide and macrophage recruitment in ApoE−/− mice
- (2012) Gillian Douglas et al. CARDIOVASCULAR RESEARCH
- Epidemiology of Obesity, the Metabolic Syndrome, and Chronic Kidney Disease
- (2012) Rikki M. Tanner et al. CURRENT HYPERTENSION REPORTS
- Allelic variations in superoxide dismutase-1 (SOD1) gene and renal and cardiovascular morbidity and mortality in type 2 diabetic subjects
- (2012) Ana Luísa Neves et al. MOLECULAR GENETICS AND METABOLISM
- Allelic variations in superoxide dismutase-1 (SOD1) gene are associated with increased risk of diabetic nephropathy in type 1 diabetic subjects
- (2011) Kamel Mohammedi et al. MOLECULAR GENETICS AND METABOLISM
- Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
- (2011) Grant R. Drummond et al. NATURE REVIEWS DRUG DISCOVERY
- The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat myocardium and protection from myocardial ischemia-reperfusion injury
- (2009) Gokulakrishnan Seshadri et al. BIOMATERIALS
- The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes
- (2009) A. Möllsten et al. DIABETOLOGIA
- Dimethyl fumarate, a small molecule drug for psoriasis, inhibits Nuclear Factor-κB and reduces myocardial infarct size in rats
- (2008) Silvia Meili-Butz et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease
- (2008) Victoria Cachofeiro et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More